Alkermes PLC (ALKS)

30.10 -1.41  -4.47% NASDAQ Oct 27, 09:30 USD
View Full Chart
Price Chart
View All ALKS News


View All Events


Date Type Description
10/27/2021 Earnings Results Q3 2021 Earnings Results
10/27/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
07/28/2021 Earnings Results Q2 2021 Earnings Results
07/28/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/14/2021 04:30 EST AGM 2020 Annual General Meeting
04/28/2021 Earnings Results Q1 2021 Earnings Results
04/28/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
02/11/2021 Earnings Results Q4 2020 Earnings Results
02/11/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Oct. 27, 2021
  • Last Earnings Release: Oct. 27, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
DDDCX 13D Activist C 3.71%
FBT First Trust NYSE Arca Biotech ETF 3.26%
SBIO ALPS Medical Breakthroughs ETF 2.99%
PBE Invesco Dynamic Biotech & Genome ETF 2.83%
KRXCX Kinetics Medical Adv C 2.73%
DOPIX BNY Mellon Opportunistic Small Cap I 1.82%
SMMV iShares MSCI USA Sm-Cp Min Vol Fctr ETF 1.03%
MISCX BNY Mellon Small Cap Multi-Strategy Inv 0.90%
VMNIX Vanguard Market Neutral I 0.83%
XBI SPDR® S&P Biotech ETF 0.80%
GSSC Goldman Sachs ActiveBeta® US SmCp Eq ETF 0.25%
F00000Z0BM Wells Fargo Factor Enhanced Small Cap Eq 0.24%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.